Commodore Capital LP

Holdings History for Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Symbol: NRIX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 3,780,055 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Commodore Capital LP ownership in Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX)

14 Nov 2025 - Commodore Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,780,055 shares of Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX). This represents 4.9% ownership of the company. In their previous filing dated 14 Feb 2025, Commodore Capital LP had reported owning 3,850,000 shares, indicating a decrease of +1.8%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Commodore Capital LP	4.9%	-4%	$34,927,708	3,780,055	-69,945	-1.8%	$9.24	13G/A	30 Sep 2025	14 Nov 2025, 17:02
COMMODORE CAPITAL LP	5.1%		$44,506,000	3,850,000			$11.56	13G	07 Feb 2025	14 Feb 2025, 16:05

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.9%	-1.9%	$43,156,750	2,275,000	-1,505,055	-40%	$18.97	Q4 2025
30 Sep 2025	1.7%	-0.08%	$34,927,708	3,780,055	-168,598	-4.3%	$9.24	Q3 2025
30 Jun 2025	3.2%	-0.02%	$44,975,158	3,948,653	-30,254	-0.76%	$11.39	Q2 2025
31 Mar 2025	3.5%	+0.86%	$47,269,415	3,978,907	+978,907		$11.88	Q1 2025
31 Dec 2024	4.1%	+1.9%	$56,520,000	3,000,000	+1,350,000	+82%	$18.84	Q4 2024
30 Sep 2024	2.3%	+2.3%	$37,075,500	1,650,000	+1,650,000	NEW	$22.47	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.